TickerFactsScreenerDevelopers

Amneal Pharmaceuticals, Inc. (AMRX) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2016: $420.77M2017: $507.48M2018: $938.77M2019: $1.15B2020: $1.33B2021: $1.32B2022: $1.43B2023: $1.57B2024: $1.77B2025: $1.91B$1.91B
2016Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$1.91B+7.4%
2024$1.77B+12.7%
2023$1.57B+10.2%
2022$1.43B+7.8%
2021$1.32B-0.4%
2020$1.33B+15.9%
2019$1.15B+22.2%
2018$938.77M+85.0%
2017$507.48M+20.6%
2016$420.77M—